Literature DB >> 11379786

Metabolism of chiisanoside from Acanthopanax divaricatus var. albeofructus by human intestinal bacteria and its relation to some biological activities.

E A Bae1, C S Yook, O J Oh, S Y Chang, T Nohara, D H Kim.   

Abstract

The metabolic pathway of chiisanoside isolated from leaves of Acanthopanax divaricatus var. albeofructus (Araliaceae) by human intestinal bacteria and by the protein fraction of leaves of this plant were investigated, and the cytotoxic and anti-rotaviral activities of chiisanoside and its metabolite, chiisanogenin, were assayed. Chiisanogenin was produced as a main metabolite, when chiisanoside were incubated for 15 h with human intestinal bacteria. This metabolic pathway proceeded more potently with the protein fraction than with human intestinal bacteria. The in vitro cytotoxicity of chiisanogenin was superior to that of chiisanoside. H+/K+ ATPase was more potently inhibited by chiisanogenin than by chiisanoside. However, the anti-rotaviral activity of chiisanoside was more potent than that of chiisanogenin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379786     DOI: 10.1248/bpb.24.582

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Acanthopanax sessiliflorus stem confers increased resistance to environmental stresses and lifespan extension in Caenorhabditis elegans.

Authors:  Jin-Kook Park; Chul-Kyu Kim; Sang-Ki Gong; A-Reum Yu; Mi-Young Lee; Sang-Kyu Park
Journal:  Nutr Res Pract       Date:  2014-09-25       Impact factor: 1.926

2.  Transcriptomic analysis of Siberian ginseng (Eleutherococcus senticosus) to discover genes involved in saponin biosynthesis.

Authors:  Hwan-Su Hwang; Hyoshin Lee; Yong Eui Choi
Journal:  BMC Genomics       Date:  2015-03-14       Impact factor: 3.969

3.  Subchronic Oral Toxicity Study of Acanthopanax divaricatus var. albeofructus in Rats.

Authors:  Myoung Jun Kim; Mi Ju Lee; Yong-Hoon Lee; Sun Hee Park; Duyeol Kim; Cheol Beom Park; Jin Seok Kang; Jong-Koo Kang
Journal:  Toxicol Res       Date:  2017-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.